6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo(d)imidazole (CAS No: 1231930-33-8) is a key pharmaceutical intermediate used in the synthesis of APIs Abemaciclib. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 6-Bromo-4-fluoro-1-isopropyl-2-methylbenzimidazole, Abemaciclib Impurity N4
CAS No: 1231930-33-8
PubChem CID: 56971662
Mol Formula: C11H12BrFN2
Mol Weight: 271.13 g/mol
Used in API: Abemaciclib
IUPAC Name: 6-bromo-4-fluoro-2-methyl-1-propan-2-ylbenzimidazole
API Intermediate Description: 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole (CAS 1231930-33-8) is primarily used as a crucial pharmaceutical intermediate (building block) in the synthesis of the targeted cancer drug Abemaciclib (Verzenio), a CDK4/CDK6 inhibitor used for advanced breast cancer, also known as Abetimib in some contexts, with its structure helping to form the core of this complex drug molecule. It's a fine chemical for R&D, not for direct human use, found in labs for drug discovery and manufacturing processes.
